Clinical Trial Update: Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Kappa-CD28 T lymphocytes in chronic lymphocytic leukemia, B-cell lymphoma, and multiple myeloma. The study is sponsored by Bay…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Chronic Lymphocytic Leukemia
• Multiple Myeloma

Drugs mentioned

• Kappa-CD28 T Lymphocytes

Snippet

Sponsor: Baylor College of Medicine | Conditions: Lymphoma, Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING